Computed tomographic (CT) brain scans were performed without and with contrast enhancement within 24 h of craniotomy in 26 patients undergoing 27 operations. Postoperative scans were retrospectively reviewed for evidence of contrast enhancement, the pattern of enhancement and the presence of blood on the postoperative scans. Contrast enhancement was seen in the resection bed in 33% of patients undergoing gross total resection of their lesions, and was absent in 50% of patients with known residual disease. Enhancement along a corticotomy was present in 18% and distant meningeal enhancement was identified in 19% of patients. These enhancement rates were unrelated to steroid dosages, duration of surgery, or the interval between operation and scanning. It was not possible to delineate residual tumor in 63% of the patients, due to a postoperative enhancement pattern that stimulated enhancing vessels, the presence of hemorrhage, or due to the absence of calcification or preoperative enhancement. None of the scans were affected by technical problems (motion artifact, inability to complete the scan) potentially associated with scanning within 24 h of craniotomy. Small amounts of residual tumor remain undetectable, particularly due to hemorrhage in the resection bed. Although no distinct advantage in defining residual disease was obtained compared to scanning at 72 h, the overall rate of findings not related to neoplasm was slightly less for scans obtained within 24 h.

Keywords:
CT scan, Postoperative contrast enhancement, Brain tumor, Residual tumor
This content is only available via PDF.
© 1995 S. Karger AG, Basel
1995
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.